Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T12:53:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice announces that NIH websites are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-26T13:28:53.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:43:23.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:29:49.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0, indicating a newer version of the record history interface.
    Difference
    0.1%
    Check dated 2026-09-21T22:09:18.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new version (v3.6.6) dated 2026-08-27 updates the Document Section, Study Design, Study Status, and Recruitment Status. This change replaces the prior Active, not recruiting status from the previous revision and marks the study as Completed, reflecting its current lifecycle stage in the study record.
    Difference
    0.6%
    Check dated 2026-08-31T17:21:07.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.